This week in MedTech, major acquisitions and targeted investments are reshaping the competitive landscape. Abbott’s $21B move for Exact Sciences, GE HealthCare’s push into AI-driven imaging with Intelerad's acquisition, and Solventum’s expansion into soft...
This week in MedTech, major acquisitions and targeted investments are reshaping the competitive landscape. Abbott’s $21B move for Exact Sciences, GE HealthCare’s push into...
GE HealthCare announced it agreed to acquire Intelerad, a medical imaging software provider, for $2.3 billion.
Chicago-based GE HealthCare plans to complete the deal in...
Okami Medical has closed a financing round, raising $45m, to expand its commercial presence and progress clinical programmes focused on improving outcomes for vascular...
FUSMobile announced that it received De Novo marketing authorization (DEN250015) from the FDA to begin marketing and sales of the Neurolyser XR system for...
Vexev and U.S. Renal Care announced successful results from the CANSCAN trial of the VxWave robotic ultrasound imaging system. Sydney, Australia-based Vexev develops the...
Hyperion Surgical announced today that it completed the world’s first robotic-assisted intravenous (IV) catheterisation using its Ivy platform.
Ivy integrates advanced imaging, AI and robotic...
AtriCure, a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announced...
Penumbra announced positive results from its landmark STORM-PE randomised controlled trial.
The study found that the use of the company’s computer-assisted vacuum thrombectomy (CAVT) system,...
This week in MedTech, major acquisitions and targeted investments are reshaping the competitive landscape. Abbott’s $21B move for Exact Sciences, GE HealthCare’s push into...
GE HealthCare announced it agreed to acquire Intelerad, a medical imaging software provider, for $2.3 billion.
Chicago-based GE HealthCare plans to complete the deal in...
Okami Medical has closed a financing round, raising $45m, to expand its commercial presence and progress clinical programmes focused on improving outcomes for vascular...
FUSMobile announced that it received De Novo marketing authorization (DEN250015) from the FDA to begin marketing and sales of the Neurolyser XR system for...